Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1137020210320060094
Journal of Gynecologic Oncology
2021 Volume.32 No. 6 p.94 ~ p.94
Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines
Cho Hyun-Woong

Min Kyung-Jin
Kwon Sang-Hoon
Kim Ki-Dong
Kim Sung-Hoon
Seong Seok-Ju
Song Yong-Jung
Lee Keun-Ho
Lee Shin-Wha
Lee Jeong-Won
Ju Woong
Kim Young-Tae
Lee Jae-Kwan
Abstract
Since the human papillomavirus (HPV) vaccine guidelines were developed by the Korean Society of Gynecologic Oncology (KSGO) in 2011, 2016, and 2019, several recent studies on the efficacy and safety of HPV vaccines in middle-aged women and men have been reported. Furthermore, there has been an ongoing debate regarding the efficacy of the HPV vaccine in women with prior HPV infection or who have undergone conization for cervical intraepithelial neoplasia (CIN). We searched and reviewed studies on the efficacy and safety of the HPV vaccine in middle-aged women and men and the efficacy of the HPV vaccine in patients infected with HPV and those who underwent conization for CIN. The KSGO updated their guidelines based on the results of the studies included in this review.
KEYWORD
Papillomavirus Vaccines, Practice Guideline, Middle Aged, Female, Male
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø